Wall Street Journal examines changes to polio eradication strategy

The Wall Street Journal examines upcoming changes to the global strategy to eradicate polio with a focus on the Bill & Melinda Gates Foundation's role in fighting the disease. "[O]rganizations behind the polio fight," which include the WHO, UNICEF, Rotary International and the CDC, "plan to announce a major revamp of their strategy to address shortcomings exposed by" the increasing number of polio outbreaks in "countries believed to have stopped the disease." The plan is expected to be announced next week.

The question regarding what to do next about polio, "goes to the heart of one of the most controversial debates in global health: Is humanity better served by waging wars on individual diseases, like polio? Or is it better to pursue a broader set of health goals simultaneously - improving hygiene, expanding immunizations, providing clean drinking water - that don't eliminate any one disease, but might improve the overall health of people in developing countries?" The newspaper reports the new polio plan will combine "both approaches. It's an acknowledgment, bred by last summer's outbreak, that disease-specific wars can succeed only if they also strengthen the overall health system in poor countries."

"The shift on polio was informed by" Gates Foundation Co-Chair Bill Gates's visit "last year to Nigeria, a nation with a history of exporting the virus to other countries." Last year, Gates Foundation "polio grants were approaching $1 billion," according to the newspaper. A Wall Street Journal reporter traveled with Gates to document the trip (Guth, 4/23).

Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Clinical trial seeks to evaluate safety of new EV-D68 treatment